TABLE 1.
Serum group | No. of samples | No. of samples positive by the following method:
|
||
---|---|---|---|---|
Reference ELISA
|
New ELISA | |||
IgM | IgG | |||
Samples known to contain anti-HEV antibodies | ||||
Anti-HEV IgM antibody positive | ||||
Nepal | 151 | 151 | 149 | 151 |
China | 38 | 38 | 38 | 38 |
Anti-HEV IgG antibody positive | ||||
Archived | 58 | 0 | 58 | 58 |
China | 18 | 0 | 18 | 18 |
Total | 265 | 189 | 263 | 265 |
Controls | ||||
Samples known to contain antibodies to other hepatitis viruses | ||||
HAVa antibody positive | 41 | 1 | 2 | 0 |
HCV antibody positive | 44 | 0 | 3 | 2 |
Other patient samples known to contain rheumatoid factor | 16 | 0 | 0 | 0 |
Samples from healthy blood donors (United States) | 323 | 3 | NDb | 3 |
Total | 424 | 4 | ND | 5 |
HAV, hepatitis A virus.
ND, not done; as healthy donor samples tested negative by a commercial ELISA for anti-HEV IgG antibodies prior to use in the study, no additional tests were done by the reference ELISA for IgG.